Gut microbiome symptoms: what they can — and cannot — tell you

The microbiome is the community of bacteria, viruses, fungi and other microorganisms living in and on the body. In the gut, these organisms interact with diet, medications, the intestinal barrier and the immune system.

There is no single “ideal” microbiome shared by every healthy person. Composition varies with geography, diet, age, medicines and many other factors.

The direction of causation is the recurring problem in this field. Where a microbial pattern differs between people with and without a condition, it is frequently unclear whether the pattern contributed to the illness or resulted from it — from altered diet, medication, inflammation or altered bowel habit. Both are plausible, and marketing almost always assumes the more convenient one.

An online symptom checklist attributing everything to dysbiosis will match almost anyone. A clinical assessment narrows it, and the explanations that emerge are generally ordinary and often treatable.

The last row is worth pausing on. Gut symptoms and anxiety genuinely influence each other, and being told symptoms are “just stress” is unhelpful and often wrong. But the relationship runs both ways, and treating only the gut when anxiety is a substantial driver leaves half the problem in place.

Sequencing can describe organisms and relative abundance in a stool sample, but interpretation for routine symptoms is not yet standardised. A single result can change with diet, recent antibiotics and sampling method.

Four specific problems

• No agreed healthy reference. There is no validated profile representing a normal microbiome, so “abnormal” on a report means differing from that company's comparison group rather than from health.
• Results are unstable. Composition shifts with recent meals, travel, illness and sampling, so the same person can produce meaningfully different reports days apart.
• Stool is not the whole gut. A faecal sample reflects the colon, and imperfectly — it does not describe the small intestine or the mucosal community.
• No validated intervention follows. Even where a finding is real, there is generally no evidence-based action that reliably changes it and improves symptoms.

Probiotics can be useful in selected situations, but effects are strain- and indication-specific. “More species” or a higher colony count does not guarantee a better product.

This is the most consistently misunderstood point in the area. Evidence supporting one strain for one condition does not transfer to a different strain, a different dose, or a different problem — any more than evidence for one antibiotic applies to all antibiotics. A product listing fifteen species at high counts is not demonstrating quality; it is demonstrating that nobody selected for a specific indication.

Probiotics also do not permanently colonise the gut in most people. Effects generally depend on continued intake, which matters for both expectation and ongoing cost.

• Eat a varied diet with adequate fibre if tolerated.
• Include a diversity of plant foods rather than chasing a single “superfood.”
• Exercise regularly.
• Prioritise sleep and stress management.
• Use antibiotics when medically indicated, not to “reset” the gut.
• Address constipation, diarrhoea or reflux with diagnosis-specific treatment.

Plant diversity has better support than any supplement in this space, and it is worth stating concretely: the number of different plant foods eaten across a week — vegetables, fruit, legumes, nuts, seeds, wholegrains, herbs — is more useful than the quantity of any single one. It is also unbranded, unsellable and therefore rarely marketed.

Recovery after antibiotics is also worth framing realistically: the microbiome shifts and generally recovers substantially over subsequent weeks to months without intervention. That process does not require a purchased protocol.

Faecal microbiota transplantation needs a doctor's assessment, screened donor material and a defined clinical goal. Its use in IBS, inflammatory bowel disease, obesity, mental health and longevity is still being studied, and results vary with the condition and the protocol. At Aquila it is considered for IBS symptom control and alongside existing treatment for IBD, never as a replacement for it.

See the next article for a detailed FMT patient guide. Our separate microbiome restoration information should not be assumed to be equivalent to formal FMT unless the exact product and route are specified.

• Blood in the stool or black stools
• Persistent or nocturnal diarrhoea
• Unintentional weight loss
• Iron-deficiency anaemia
• Fever or severe abdominal pain
• New bowel-habit change in an older adult
• Family history of inflammatory bowel disease or colorectal cancer

These findings should not be managed with supplements or microbiome optimisation alone. Diarrhoea that wakes you at night is particularly worth noting, because functional conditions such as IBS typically do not, and that single detail often changes the direction of assessment.